Landfar Bio-medicine Co., Ltd (SHE:000504)
8.85
-0.45 (-4.84%)
At close: Jan 23, 2026
Landfar Bio-medicine Revenue
Landfar Bio-medicine had revenue of 31.85M CNY in the quarter ending September 30, 2025, a decrease of -11.76%. This brings the company's revenue in the last twelve months to 125.47M, up 0.82% year-over-year. In the year 2024, Landfar Bio-medicine had annual revenue of 134.45M, down -1.71%.
Revenue (ttm)
125.47M
Revenue Growth
+0.82%
P/S Ratio
23.28
Revenue / Employee
331.93K
Employees
378
Market Cap
2.92B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 134.45M | -2.34M | -1.71% |
| Dec 31, 2023 | 136.79M | -63.55M | -31.72% |
| Dec 31, 2022 | 200.35M | 43.73M | 27.92% |
| Jan 1, 2022 | 156.62M | -18.95M | -10.79% |
| Dec 31, 2020 | 175.56M | 41.40M | 30.86% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shanghai Universal Biotech | 1.07B |
| Shandong Sito Bio-technology | 954.76M |
| Zhejiang East Asia Pharmaceutical | 831.56M |
| Guangdong VTR Bio-Tech | 830.87M |
| Jilin Jian Yisheng Pharmaceutical | 639.10M |
| Cabio Biotech (Wuhan) | 596.47M |
| Suzhou Fushilai Pharmaceutical | 439.57M |
| Jiangsu Sihuan Bioengineering | 341.90M |